Chalice Brands, a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale and distribution, was recognized for its proprietary genetics program, state-of-the-art grow facility and cultivated products at the prestigious 2021 Oregon Growers Cup, taking home first place for 1:1 flower and third place for tincture at the annual awards event on Saturday, Dec. 4.
“We are extremely proud to place first in this category at our first cup,” said Meghan Miller, Chief Operating Officer at Chalice Brands. “We kicked off our in-house breeding program 18 months ago with the goal of creating best-in-class genetics. It’s an absolute honor to be recognized by such a beloved event.”
The Oregon Growers Cup, the premier cannabis cultivation competition in Oregon and one of the first industry-specific awards held in the state, provides medical, recreational and home growers the chance to showcase their Oregon-grown cannabis. The annual awards event, in its seventh year, has grown to be the biggest cannabis competition in the state, with more than 300 entries and over 65 vendors in 2020. Chalice Brands’ Strawberry Remedy #9 was awarded first place in the 1:1 flower category, while Elysium Fields Mob Boss blended live resin was awarded third place for tincture. Strawberry Remedy #9, the introductory product from Chalice Brand’s proprietary genetics program, was cultivated at the company’s greenhouse grow facility, Bald Peak Farm, which yields new, top-quality strains each month, with unmatched legacy through its advanced proprietary genetics program.
“We’re honored to be recognized for all of the hard work that we’re putting into our proprietary genetics program,” said Derek Rayhorn, Director of Cultivation at Bald Peak Farm. “Our Strawberry Remedy #9 strain brings a relaxed effect when consumed, and the buds are dense with a colorful array of green, purple and orange with a fresh strawberry smoothie scent. We are also very proud of our Mob Boss tincture, an excellent choice to achieve the ‘entourage-effect.’”
Chalice Brands’ genetics program is the brainchild of Miller and Rayhorn, which utilizes their combined 20 years of experience. “Derek and I both believe mixed-ratio flower will drive the market in the coming years, and we’re committed to delivering top-quality strains to our consumers,” said Miller.
Chalice Brands’ Strawberry Remedy #9 strain with 1:1 CBD:THC is a combination of the two unique terpene profiles from Dragon Desert Frost and Strawberry Fields, creating a balanced ratio that encourages a relaxing experience. Chalice Brands’ Elysium Fields Mob Boss tincture, 1:1 CBD:THC, with 30% live resin and 70% distillate, is hand-crafted in strain-specific small batches with high-quality MCT oil and high-potency THC distillate to formulate a smooth delivery and a true-to-the-plant experience.
Chalice Brands’ Bald Peak Farm is a 10,000-square-foot grow facility, with three greenhouses that house hundreds of plants. Located 1,600 feet above sea level at the Chehalem Mountain range, Bald Peak flower reaps the benefits of seclusion from urban areas and farmland, which lessens the risk of exposure to pollution. Bald Peak has advanced, self-automated grow techniques, from watering systems to light deprivation and access, and deploys high-tech practices used daily, to ensure that quality and testing aligns with and exceeds expectations.
Chalice Brands’ Strawberry Remedy #9 flower and Elysium Fields Mob Boss tincture are available now across all Chalice Brands dispensaries, including Chalice Farms, Left Coast Connection, Homegrown Oregon and Cannabliss & Co. locations.
Chalice Farms encourages customers to take advantage of its online ordering platform, plus delivery and express pick-up offerings. The company’s online ordering platform allows customers to reserve products, select options for pick-up in store, have products delivered or utilize curbside pick-up. Chalice Farms offers complimentary delivery services for orders of $60 or more, available daily beginning at noon. Deliveries are collected and distributed on an hourly basis, with an estimated wait time of 30 to 90 minutes.